Renovaro Inc. Files 8-K Amendment for Director Appointment Details
Ticker: LNAI · Form: 8-K/A · Filed: Oct 29, 2024 · CIK: 1527728
| Field | Detail |
|---|---|
| Company | Renovaro Inc. (LNAI) |
| Form Type | 8-K/A |
| Filed Date | Oct 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, director-appointment, corporate-governance
TL;DR
Renovaro Inc. 8-K/A filed 10/29, adding details on director appointments from 10/16 8-K.
AI Summary
Renovaro Inc. filed an amendment (8-K/A) on October 29, 2024, to its October 16, 2024, Form 8-K. This amendment is solely to provide information required by Item 5.02(d)(3) of Form 8-K, related to the appointment of directors previously reported.
Why It Matters
This filing clarifies previously reported director appointments, providing necessary details to the SEC and investors.
Risk Assessment
Risk Level: low — The filing is an amendment to provide supplementary information on previously disclosed director appointments, not a new material event.
Key Players & Entities
- Renovaro Inc. (company) — Filer of the 8-K/A and Original 8-K
- SEC (company) — Recipient of the filing
- October 16, 2024 (date) — Date of the Original 8-K filing
- October 29, 2024 (date) — Date of the 8-K/A filing
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A is filed solely to provide information called for in Item 5.02(d)(3) of Form 8-K, related to the appointment of directors.
What was the original filing this 8-K/A amends?
This 8-K/A amends the Current Report on Form 8-K filed by Renovaro Inc. on October 16, 2024.
When was the original Form 8-K filed?
The original Form 8-K was filed on October 16, 2024.
What specific item of Form 8-K does this amendment address?
This amendment addresses Item 5.02(d)(3) of Form 8-K.
What was the subject of the Original 8-K filing?
The Original 8-K reported the appointment of certain directors of Renovaro Inc.
Filing Stats: 628 words · 3 min read · ~2 pages · Grade level 12.4 · Accepted 2024-10-29 16:21:10
Key Financial Figures
- $0.0001 — ch Registered Common Stock, par value $0.0001 per share RENB The Nasdaq Stock Mar
Filing Documents
- e6067_8-ka.htm (8-K/A) — 26KB
- 0001731122-24-001672.txt ( ) — 201KB
- renb-20241011.xsd (EX-101.SCH) — 3KB
- renb-20241011_lab.xml (EX-101.LAB) — 33KB
- renb-20241011_pre.xml (EX-101.PRE) — 24KB
- e6067_8-ka_htm.xml (XML) — 5KB
02 Departure of Directors or Certain Officers;
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Committee Appointment of Directors On October 23, 2024, the Board appointed (i) Maurice van Tilburg as a member of the Company's Nominating and Governance Committee and Special Litigation Committee effective immediately, (ii) James McNulty as a member and Chair of the Company's Audit Committee, as well as a member of the Company's Special Litigation Committee and Compensation Committee effective immediately, (iii) Douglas Calder as a member of the Company's Audit Committee, Nominating and Governance Committee and Compensation Committee effective immediately, and (iv) Dr. Mark Collins as a member of the Company's Audit Committee and Special Litigation Committee effective immediately. Each of the directors will enter into standard indemnification agreements with the Company in the same form that the Company has entered into with its other directors.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RENOVARO INC. By: /s/ Simon Tarsh Name: Simon Tarsh Title: Interim Chief Financial Officer Date: October 29, 2024